We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Lennar Class A
LEN
$20.3B
| $13.4M | 0.12% |
80,331
-175,333
| -69% | -$26.4M |
|
227
CSX Corp
CSX
$94.5B
| $13.3M | 0.12% |
+358,826
| New | +$13.1M |
|
228
Corning
GLW
$136B
| $13.2M | 0.12% |
+401,899
| New | +$12.8M |
|
|
MRSN
229
DELISTED
Mersana Therapeutics
MRSN
| $13.1M | 0.12% |
+117,385
| New | +$11.7M |
|
230
Lattice Semiconductor
LSCC
$18.3B
| $13.1M | 0.12% |
167,633
+100,059
| +148% | +$7.16M |
|
231
Dell
DELL
$287B
| $13M | 0.12% |
113,952
-92,532
| -45% | -$8.63M |
|
232
Boston Scientific
BSX
$71.6B
| $12.8M | 0.12% |
187,296
-278,822
| -60% | -$17.9M |
|
233
EPAM Systems
EPAM
$4.98B
| $12.8M | 0.12% |
+46,272
| New | +$13.6M |
|
234
Paylocity
PCTY
$8.3B
| $12.6M | 0.12% |
+73,464
| New | +$12.1M |
|
|
STKL
235
DELISTED
SunOpta
STKL
| $12.6M | 0.12% |
1,833,473
-299,265
| -14% | -$1.85M |
|
236
Domino's
DPZ
$11.9B
| $12.2M | 0.11% |
24,525
-5,484
| -18% | -$2.38M |
|
237
Allogene Therapeutics
ALLO
$670M
| $11.8M | 0.11% |
2,633,976
+56,476
| +2% | +$236K |
|
238
Woodward
WWD
$21.7B
| $11.7M | 0.11% |
+76,237
| New | +$10.7M |
|
239
Roper Technologies
ROP
$38.8B
| $11.6M | 0.11% |
+20,607
| New | +$11.2M |
|
240
AnaptysBio
ANAB
$1.62B
| $11.5M | 0.11% |
508,839
-686,135
| -57% | -$16.2M |
|
|
SPR
241
DELISTED
Spirit AeroSystems
SPR
| $11.4M | 0.11% |
+316,715
| New | +$9.6M |
|
242
GFL Environmental
GFL
$14.9B
| $11.4M | 0.11% |
330,607
+197,120
| +148% | +$6.81M |
|
243
Biohaven
BHVN
$2.16B
| $11.4M | 0.1% |
208,478
-534,637
| -72% | -$26.5M |
|
244
Globe Life
GL
$14.4B
| $11.2M | 0.1% |
+96,224
| New | +$11.8M |
|
245
Mohawk Industries
MHK
$8.98B
| $11.2M | 0.1% |
+85,322
| New | +$9.59M |
|
246
CRISPR Therapeutics
CRSP
$5.05B
| $11.1M | 0.1% |
163,577
+113,544
| +227% | +$8.13M |
|
247
Jasper Therapeutics
JSPR
$22M
| $11.1M | 0.1% |
379,246
+205,947
| +119% | +$3.66M |
|
248
Intapp
INTA
$2.78B
| $11.1M | 0.1% |
+322,784
| New | +$12.7M |
|
|
APLS
249
DELISTED
Apellis Pharmaceuticals
APLS
| $11M | 0.1% |
186,998
+774
| +0.4% | +$49.3K |
|
250
Fortune Brands Innovations
FBIN
$6.05B
| $11M | 0.1% |
+129,476
| New | +$10.3M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.